Korro Bio Appoints New CMO, Elects Director
Ticker: KRRO · Form: 8-K · Filed: Jun 21, 2024 · CIK: 1703647
| Field | Detail |
|---|---|
| Company | Korro Bio, Inc. (KRRO) |
| Form Type | 8-K |
| Filed Date | Jun 21, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-election, executive-compensation
TL;DR
Korro Bio brings in a new CMO and adds a director to the board.
AI Summary
Korro Bio, Inc. announced on June 17, 2024, the appointment of Dr. Michael J. Yauch as Chief Medical Officer and the election of Dr. Sarah E. Kelley to its Board of Directors. The company also disclosed compensatory arrangements for its named executive officers, including Dr. Yauch, as part of its ongoing operations in the pharmaceutical preparations sector.
Why It Matters
Changes in key leadership roles like Chief Medical Officer and Board of Directors can signal shifts in strategic direction and operational focus for a biotechnology company.
Risk Assessment
Risk Level: medium — Changes in executive and board positions can indicate internal shifts that may impact future performance and strategy.
Key Numbers
- 001-39062 — SEC File Number (Identifies Korro Bio's filing history with the SEC.)
- 47-2324450 — IRS Employer Identification No. (Tax identification number for Korro Bio.)
Key Players & Entities
- Korro Bio, Inc. (company) — Registrant
- Dr. Michael J. Yauch (person) — Appointed Chief Medical Officer
- Dr. Sarah E. Kelley (person) — Elected to Board of Directors
- June 17, 2024 (date) — Date of earliest event reported
- Frequency Therapeutics, Inc. (company) — Former company name
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Michael J. Yauch has been appointed as the Chief Medical Officer.
Who has been elected to Korro Bio's Board of Directors?
Dr. Sarah E. Kelley has been elected to Korro Bio's Board of Directors.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is June 17, 2024.
What is Korro Bio's former company name?
Korro Bio, Inc.'s former company name was Frequency Therapeutics, Inc.
What is the principal executive office address for Korro Bio?
The principal executive office is located at One Kendall Square, Building 600-700, Suite 6-401, Cambridge, MA 02139.
Filing Stats: 387 words · 2 min read · ~1 pages · Grade level 11.2 · Accepted 2024-06-21 16:15:54
Key Financial Figures
- $0.001 — ich registered Common stock, par value $0.001 per share KRRO The Nasdaq Capital M
Filing Documents
- d847854d8k.htm (8-K) — 22KB
- 0001193125-24-165684.txt ( ) — 148KB
- krro-20240617.xsd (EX-101.SCH) — 3KB
- krro-20240617_lab.xml (EX-101.LAB) — 19KB
- krro-20240617_pre.xml (EX-101.PRE) — 12KB
- d847854d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. KORRO BIO, INC. Date: June 21, 2024 By: /s/ Ram Aiyar Name: Ram Aiyar Title: President and Chief Executive Officer